LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B (Q2906914): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in pt, en, fr, de, nl, it, es, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,) |
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
||
| label / pt | label / pt | ||
LIPOPREDICT .: Previsão da resposta dos pacientes a fármacos antineoplásicos lipossomais: focando na atividade endocítica do LRP1B | |||
| label / en | label / en | ||
LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B | |||
Revision as of 12:42, 24 August 2022
Project Q2906914 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B |
Project Q2906914 in Portugal |
Statements
203,733.0 Euro
0 references
239,686.0 Euro
0 references
85.0 percent
0 references
15 July 2018
0 references
14 July 2021
0 references
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
0 references
Q2993205 (Deleted Item)
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-031520
0 references